ex CFO @endrarediseases | Studying the languages of molecules & mycelium - DeSci advocate with @bio_hacker_dao. Building science that can’t be locked away.
Free Peptide AI Assistant
Some platforms charge $99/mo for "AI-powered peptide guidance."
We think charging for publicly available information is absurd. Meet Peppy. Ask anything about peptides. Research, dosing, protocols, regulations.
People mistakenly believe peptides are only good.
Peptides can be bad, too.
They can cause adverse effects. Some dangerous.
I did a peptide experiment and measured its effects in my body. The results are complicated.
I tried a peptide called CJC-1295.
It pushed my growth hormone up by ~8x. That’s good. That’s what it was supposed to do.
But, it also came with adverse effects:
> increased my morning fasted blood sugar up 20%
> increased stress hormone by 12%
> tanked my REM sleep by 23%
> made my pancreas work 53% harder and was still losing to rising blood glucose
> increased my insulin resistance by 50%
These were the most obvious side effects, and I only ran a very narrow panel for this experiment.
So I’m sure there’s more.
I stopped after two doses, without even reaching the intended target dose.
For those of you new to peptides, your body sends instructions to itself using tiny chemical messengers called peptides. There are thousands of them.
For example, GLP-1s are drugs that take an existing class of short-lived peptides and modify them to extend their activity duration, which turns them into drugs, following rigorous clinical testing.
CJC-1295 is one of those peptide-drugs. It tells your brain to release more growth hormone. Growth hormone is your body's signal to build muscle, repair tissue, and recover.
However, and like most grey market peptides, CJC-1295 did not succeed its clinical trial, and hence never became an “official” drug.
There is a version called CJC-1295 with DAC. DAC is an attachment glued onto the peptide that makes it last for days in your body instead of hours. One shot, longer effect, just like GLP-1s.
Why people use it: more growth hormone could mean better recovery, leaner body, faster healing.
The experiment I completed.
Two injections a week of CJC-1295 with DAC:
> 1.2 mg
> 1.8 mg
48 hours after the first injection I was nearly comatose. It felt like severe jet lag, the type you’d feel after traveling nine time zones. My sleep was wrecked and I felt continuously awful.
My REM sleep dropped by 23%. REM is when your brain processes memories and repairs itself. Less time for my brain to repair itself. During the experiment, I never felt rested and always fatigued.
Why we chose CJC-1295 with DAC.
Some will say we picked the wrong peptide. They will say I should have used a different version, CJC-1295 without DAC, mixed with another peptide called Ipamorelin. We went with CJC-1295 with DAC instead as it has the most controlled studies.
CJC-1295 with DAC has 2 controlled trials in healthy adults. Ipamorelin alone has 1 controlled trial in healthy adults, plus 1 study that failed when they tried it on bowel surgery patients. The mix of the two has zero controlled trials.
On Ipamorelin, it copies a chemical called ghrelin, the one that makes you hungry. On its own it gives you a quick burst of growth hormone that fades fast. It does not keep your longer acting growth signal (called IGF-1) up. Clinics mix Ipamorelin with CJC-1295 no-DAC because the two together are supposed to work better. But we don’t know if that’s accurate because we don’t have trial data.
This is a problem with peptides. Almost none of them have been tested properly. We are flying blind. Most of what people use is based on what someone said online, what a clinic claims, or what a friend reports from their subjective feelings.
Peptides have the potential to be great when well-studied.
@BioProtocol 14 days is pretty long day, and i already made it free there, you can use it completly free
no need preasle. or staking bio etc etc
|https://t.co/PbBBASPmMn
Free Peptide AI Assistant
Some platforms charge $99/mo for "AI-powered peptide guidance."
We think charging for publicly available information is absurd. Meet Peppy. Ask anything about peptides. Research, dosing, protocols, regulations.
2,847 longevity pathway peptide analogs (senomorphic, sirtuin, autophagy & NAD+ boosters) just dropped as public-domain prior art (§102).
Full sequences, predicted structures, PK/PD models, and composite scores — all open on Zenodo and now integrated
This is part of the largest & highest-quality model-generated peptide library ever built specifically for DeSci longevity research. Still ~280,000 more high-edit-distance candidates with readiness tiers, zero gatekeeping.
No patents. No paywalls. Pure bio/acc acceleration.
Links:
https://t.co/HeYmbuJzF5
Building science that can’t be locked away with @bio_hacker_dao
DM @adeeeewarchive or [email protected] for outreach
Free Peptide AI Assistant
Some platforms charge $99/mo for "AI-powered peptide guidance."
We think charging for publicly available information is absurd. Meet Peppy. Ask anything about peptides. Research, dosing, protocols, regulations.
Free Peptide AI Assistant
Some platforms charge $99/mo for "AI-powered peptide guidance."
We think charging for publicly available information is absurd. Meet Peppy. Ask anything about peptides. Research, dosing, protocols, regulations.
Longevity Biotech Atlas 🔥
Finally a real map of the entire ecosystem. Peptides + rejuvenation tech are cooking.
Building exactly in this lane with open AI tools for peptide discovery @PeptideIQ — no paywalls, pure DeSci acceleration.
This atlas is going to be core infrastructure. Count me in for updates 👀
Superhuman Fund II 🔥
Peptides + human enhancement is exactly where the real acceleration is happening.
Been building open AI tools for peptide discovery (PeptideIQ) so researchers can move faster without paywalls or gatekeepers. Fully aligned with the bio/acc thesis — science that can’t be locked away.
Would love to see how y’all think about DeSci infrastructure & open data rails for these upgrades.
DM open if you wanna chat peptides / longevity stack 👀
@bio_hacker_dao
Peptide drug discovery now has an autonomous pipeline.
A tool takes an input and returns an output. A sequence goes in, a structure comes back.
The decision of what to do with it, whether the structure is good enough, what to run next, whether the candidate advances, stays with the researcher.
An agent uses tools. It evaluates the output against a defined threshold, decides whether the candidate passes or fails, and triggers the next step without waiting for a human to interpret the result.
@peptai_ is built as a fleet of agents. Each agent targets a specific receptor and runs the full 9-gate pipeline: source novel candidates, calibrate the quality gates, run the computational analysis, and hand survivors to wet lab.
Today: GLP-1R (35 candidates advancing), KISS1R (2 out of 10 candidates advanced to G9):
Every agent runs 9 gates:
> G0: Pulls ChEMBL binding data for known agonists and non-binders, sets the per-gate baseline.
> G1-G3: AlphaFold and Boltz2. Structure quality, binding poses, contact conservation.
> G4-G5: PRODIGY for affinity, LiteFold's MD for stability.
> G6-G8: PROSPERousPlus, PlifePred, OpenSol, and ToxinPred3. Proteolytic stability, solubility, aggregation, off-target safety.
> G9: Wet lab handoff with @adaptyvbio. The goal is to have synthesis paid machine-to-machine via x402.
Only sequences that clear all G1 through G8 earn a synthesis recommendation. G9 is wet lab only and cannot be computationally overridden.
Every gate decision is published openly on Molecule Labs.
PeptAI is experimental and actively evolving. Gates, tools, and thresholds change as the pipeline learns.
Free Peptide AI Assistant
Some platforms charge $99/mo for "AI-powered peptide guidance."
We think charging for publicly available information is absurd. Meet Peppy. Ask anything about peptides. Research, dosing, protocols, regulations.
If this is useful, share it with someone who's overpaying for information that should be free.
And if you know what you paid for a peptide, submit it anonymously on our cost page. More data makes this better for everyone.